| Primary |
| Schizophrenia |
46.7% |
| Product Used For Unknown Indication |
10.9% |
| Drug Use For Unknown Indication |
8.3% |
| Psychotic Disorder |
8.0% |
| Schizophrenia, Paranoid Type |
5.8% |
| Schizoaffective Disorder |
4.0% |
| Bipolar Disorder |
3.3% |
| Delusional Disorder, Unspecified Type |
2.5% |
| Acute Psychosis |
2.2% |
| Post-traumatic Stress Disorder |
1.4% |
| Schizoid Personality Disorder |
1.4% |
| Hypertension |
1.1% |
| Delirium |
0.7% |
| Depression |
0.7% |
| Drug Exposure During Pregnancy |
0.7% |
| Schizotypal Personality Disorder |
0.7% |
| Accidental Exposure To Product |
0.4% |
| Delusion |
0.4% |
| Delusional Disorder, Persecutory Type |
0.4% |
| Diabetes Mellitus |
0.4% |
|
| Completed Suicide |
15.6% |
| Hospitalisation |
12.5% |
| Suicide Attempt |
11.5% |
| Schizophrenia |
9.4% |
| Disease Progression |
7.3% |
| Suicidal Ideation |
5.2% |
| Treatment Noncompliance |
5.2% |
| Weight Increased |
4.2% |
| Aggression |
3.1% |
| Lethargy |
3.1% |
| Neuroendocrine Tumour |
3.1% |
| Off Label Use |
3.1% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Eye Swelling |
2.1% |
| Hallucination |
2.1% |
| Hyperprolactinaemia |
2.1% |
| Hyponatraemia |
2.1% |
| Inappropriate Schedule Of Drug Administration |
2.1% |
| Restlessness |
2.1% |
| Somnolence |
2.1% |
|
| Secondary |
| Schizophrenia |
35.0% |
| Product Used For Unknown Indication |
21.4% |
| Psychotic Disorder |
16.7% |
| Schizophrenia, Paranoid Type |
9.4% |
| Drug Use For Unknown Indication |
3.4% |
| Post-traumatic Stress Disorder |
3.1% |
| Acute Psychosis |
2.1% |
| Anxiety |
2.1% |
| Delusional Disorder, Unspecified Type |
1.6% |
| Bipolar Disorder |
1.0% |
| Schizoaffective Disorder |
1.0% |
| Delirium |
0.5% |
| Depression |
0.5% |
| Mental Disorder |
0.5% |
| Myocardial Ischaemia |
0.5% |
| Personality Disorder |
0.5% |
| Hypertension |
0.3% |
| Ill-defined Disorder |
0.3% |
|
| Suicide Attempt |
17.2% |
| Treatment Noncompliance |
17.2% |
| Schizophrenia |
6.9% |
| Weight Increased |
6.9% |
| Dyskinesia |
5.2% |
| Restlessness |
5.2% |
| Spinal Osteoarthritis |
5.2% |
| Completed Suicide |
3.4% |
| Disease Progression |
3.4% |
| Hallucination, Auditory |
3.4% |
| Neuroendocrine Tumour |
3.4% |
| Off Label Use |
3.4% |
| Suicidal Ideation |
3.4% |
| Suspiciousness |
3.4% |
| Tremor |
3.4% |
| Aggression |
1.7% |
| Cardiac Failure Acute |
1.7% |
| Death |
1.7% |
| Depression |
1.7% |
| Eye Swelling |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
50.0% |
| Schizophrenia |
50.0% |
|
|
